Matrix metalloproteinases (MMPs) drive normal tissue remodeling and are implicated in a wide range of pathologies. Although MMP activity is controlled at multiple levels, the primary regulation of MMP activity is transcriptional. The transcriptional promoter elements required for MMP gene expression in cultured cells have been defined, but this has not been extended to the in vivo situation. In this paper, we show that the DNA sequences between ؊522 and ؉19 of the rabbit gelatinase B gene (MMP-9) (as characterized in the transgenic mouse line 3445) constitute a minimal promoter that drives appropriate developmental and injury-induced reporter gene expression in transgenic mice. We further show that the expression and activity of three transcription factors (NF-B, AP-2, and Sp1) that control the activity of the gelatinase B promoter are selectively induced in the epithelium migrating to heal a wound. Although promoter activity parallels expression of the endogenous gene in cell cultures, we show by several criteria that cell cultures cannot model many aspects of promoter regulation in vivo. This study reveals that the transgenic mouse line 3445 might be a useful model for investigating the regulation of gelatinase B expression in vivo and for identifying and characterizing new drugs that can control gelatinase B gene transcription.
Matrix metalloproteinases (MMPs) drive normal tissue remodeling and are implicated in a wide range of pathologies. Although MMP activity is controlled at multiple levels, the primary regulation of MMP activity is transcriptional. The transcriptional promoter elements required for MMP gene expression in cultured cells have been defined, but this has not been extended to the in vivo situation. In this paper, we show that the DNA sequences between ؊522 and ؉19 of the rabbit gelatinase B gene (MMP-9) (as characterized in the transgenic mouse line 3445) constitute a minimal promoter that drives appropriate developmental and injury-induced reporter gene expression in transgenic mice. We further show that the expression and activity of three transcription factors (NF-B, AP-2, and Sp1) that control the activity of the gelatinase B promoter are selectively induced in the epithelium migrating to heal a wound. Although promoter activity parallels expression of the endogenous gene in cell cultures, we show by several criteria that cell cultures cannot model many aspects of promoter regulation in vivo. This study reveals that the transgenic mouse line 3445 might be a useful model for investigating the regulation of gelatinase B expression in vivo and for identifying and characterizing new drugs that can control gelatinase B gene transcription.
Removal of ECM
1 structures is an important component of normal tissue remodeling, and excessive or inappropriate ECM degradation is the basis of a number of pathologies. The major effectors of ECM degradation belong to a family of structurally related enzymes called matrix metalloproteinases (MMPs) (1) . MMPs share several properties that reflect the multiple levels at which their activity is regulated. These include secretion in an inactive pro-form requiring activation by proteolytic cleavage, requirement for zinc in the active site, and capacity of the active enzyme to be inhibited by members of the TIMP (tissue inhibitor of metalloproteinases) family (2) . Currently, there is much interest in the development of drugs to inhibit MMP activity that take advantage of the shared biochemical properties of these enzymes (3) .
Although MMP activity is controlled at multiple levels, resident cells of a tissue typically do not make MMPs unless they are needed for remodeling (4) . Therefore, regulation of MMP gene expression offers a second possible drug target for controlling inappropriate MMP activity. Expression of MMPs is controlled primarily at the level of transcription (5) . A large number of agents and conditions stimulate MMP transcription (6, 7) , but only a few with inhibitory properties are known (4, 5) . Currently, identification of MMP transcriptional inhibitors can be made in cultured cell models. However, to begin evaluation of compounds with transcriptional inhibitory properties for efficacy in specific disease processes, animal models must be developed that make use of rapid and simple assays. One approach would be to introduce easily assayed reporter genes under control of a specific MMP promoter into transgenic mice. Development of this type of model would be able to rely on the extensive work characterizing the requirements for MMP promoter activity in cultured cells; however, the promoter requirements are likely to be far more complex in animals. We are aware of no studies characterizing promoter sequences in mice for any MMP gene to date.
Gelatinase B (MMP-9) was one of the first members of the MMP family to be characterized (8) . This MMP is reactive against native type IV and V collagens, elastin, fibronectin, and denatured collagens of all types (9, 10) . At first thought to be specific for polymorphonuclear leukocytes (11) and macrophages (12) , it is now known to be expressed by the resident cells of a variety of different tissues (13) (14) (15) (16) . Expression of the gelatinase B (gelB) gene in tissues is developmentally regulated. Major sites of expression include trophoblast cells surrounding the implanting embryo (17) as well as the brain and skeletal elements of the embryo proper (18 -20) . In adults, gelB is expressed in brain (21) as well as in bone osteoclasts (18, 22) . Expression in adults is also inducible at a number of sites by stress stimuli. For example, gelB is not expressed in the epidermis or dermis of adult skin; however, expression is induced in the basal cell layers of the epidermis (23, 24) or corneal epithelium (25) migrating to resurface a wound. Much like other MMPs, inappropriate or excessive gelB expression is associated with a number of pathological conditions. Sites of pathological expression include the epithelium of ulcerating corneas (26, 27) , the brain of Alzheimer's disease patients (21) , the tumor cells of metastatic cancers (28) , the vessel walls of aortic aneurysms (29) , and smooth muscle cells and fibroblasts surrounding inflamed vessels in patients with giant cell arthitides (30) .
In cell cultures, gelB expression is stimulated by growth factors and inflammatory cytokines such as transforming growth factor-␤, interleukin-1, and tumor necrosis factor-␣ and tumor-promoting phorbol esters such as TPA (4) . These stimulators also coordinately induce other MMP genes such as collagenase and stromelysin; however, the signaling pathways for gelB appear to be different (31) . 2 The DNA flanking the 5Ј-end of the gelB gene is highly conserved across the human, mouse, and rabbit species from the transcription start site (ϩ1), upstream through base Ϫ600. In common with many other MMPs, a canonical TPA response element that binds transcription factor AP-1 is found close to the transcription start site (33); a second TPA response element is located near the distal end of the conserved region (34 -37) . At least one of these TPA response elements must be intact for promoter activity in cultured cells (37) . Other sequence motifs that confer response to transcription factors NF-B, Sp1, and AP-2 (35-38) play a part in the unique expression characteristics of the gelB gene.
In this report, we advance MMP promoter characterization to the next level by investigating the regulatory sequences of the gelB promoter that confer expression in transgenic mice. We show that sequences between Ϫ522 to ϩ19 of the gelB promoter, as characterized in the transgenic mouse line 3445, are necessary and sufficient for appropriate developmental and wound-inducible expression of a lacZ reporter gene. We further show that the expression and activity of three transcription factors that control the gelB promoter in cultured cells (NF-B, AP-2, and Sp1) are selectively induced in the epithelium migrating to close the wound in vivo. Although promoter activity parallels expression of the endogenous gene in cell cultures, we show that cell cultures cannot model many aspects of promoter regulation in vivo. These studies suggest that the transgenic mouse line 3445 might be a useful model for investigating the unique regulation characteristics of gelB gene expression and for identifying and characterizing new drugs that can control gelB gene transcription.
MATERIALS AND METHODS
Cell Culture-The rabbit synovial cell line HIG-82, a gift from Dr. C. H. Evans (39), was cultured as described (14) . Primary corneal epithelial cells were isolated and cultured as described (14, 31) . The rabbit corneal "epithelial-like" cell line SIRC (American Type Culture Collection, Rockville, MD) and the mouse keratinocyte cell line PAM-212 (a gift from Dr. Paolo Dotto, Massachusetts General Hospital) were cultured as recommended by the suppliers.
Construct Development and Transient Transfection Analysis-Construct Pr43 was created using a two-step cloning strategy. A 541-base pair fragment extending from Ϫ522 to ϩ19 of the rabbit gelB gene was PCR-amplified from rabbit genomic clone p36 (37) using the Puc/M13 forward primer (5Ј-GTA AAA CGA CGG CCA GT-3Ј; Promega, Madison, WI) and primer BF6 (5Ј-CGC GGG CTC GAG GGT GAG GGG AGA AGC GCT-3Ј) complementary to bases ϩ19 to ϩ2, with an XhoI site and a GC clamp added to the 5Ј-end. The resulting PCR product was cut with EcoRI (base Ϫ522) and XhoI and cloned into the pNASS␤ expression vector (Promega). This construction is called Pr22. The 4666-base pair fragment from Pr22 containing the Ϫ522 to ϩ19 gelB promoter/ lacZ fusion gene was next cut with EcoRI/HindIII and cloned into pcDNA3 (Invitrogen, San Diego, CA). The cytomegalovirus promoter from pcDNA3 was then removed by digestion with NruI and HindIII; the remaining plasmid ends were blunt-ended; and the ends were religated to produce Pr43 (see Fig. 1 ).
An intermediate construct, Pr34, was created to facilitate the construction of the deletion constructs Pr35 and Pr42. To do this, the proximal region (Ϫ92 to ϩ19) of the gelB promoter was PCR-amplified using a forward primer (5Ј-CGC GGG CTC GAG CAC CGG CCC TGA GTC AGC ACT-3Ј) and a reverse primer (5Ј-CGC GGG GTC GAC GGT GAG GGG AGC AGC AGC GTC T-3Ј). An XhoI site terminated by a GC clamp was added to the 5Ј-end of the forward primer. A SalI site terminated by a GC clamp was added to the 5Ј-end of the reverse primer. The amplified DNA fragment was cut with XhoI/SalI and cloned into the XhoI site of pNASS␤. Construct Pr35 was created by introducing the sequences from the distal AP-1 site to just upstream of the NF-B site (Ϫ566 to Ϫ438) and fusing this fragment to the Ϫ92 to ϩ19 gelB sequences contained in Pr34. The distal promoter sequences were PCR-amplified using the forward primer (5Ј-CGC GGG CTC GAG  CCC ATC ACT GCC CTG AAG ATTC-3Ј) and the reverse primer (5Ј-CGC GGG CTC GAG AAA GCC CTC CTC TGA CTC AGC TTC-3Ј) ; each primer was 5Ј-terminated by an XhoI site-GC clamp. The PCR-amplified DNA fragment was cut with XhoI and cloned into Pr34 at the XhoI site. Pr42 was created by amplifying the gelB promoter between Ϫ566 and Ϫ313 using the same forward primer as for Pr35 and a reverse primer containing the XhoI site-GC clamp (5Ј-CGC GGG CTC GAG TGG TCA GCT CAG CGA AAG GAT-3Ј). The PCR-amplified DNA fragment was cut with EcoRI (which removes DNA sequences upstream of the NF-B site beginning at base Ϫ523) and XhoI and cloned into EcoRI/XhoI-cut Pr34, upstream of the Ϫ92 to ϩ19 gelB promoter sequences. Plasmid DNAs were purified using the QIAGEN plasmid DNA purification kit.
Development of Stably Transfected Keratinocyte Cell Lines-Pr43 plasmid DNA was transfected into SIRC and PAM-212 cells using LipofectAMINE reagent (Life Technologies, Inc.) following the procedure of the manufacturer. Cells were cultured in medium containing the antibiotic drug G418 (Geneticin, Life Technologies, Inc.) at 0.625 mg/ml. Drug-resistant stably transfected cells were identified as discrete surviving colonies after 1 month of selection in culture. To determine whether transfected cells expressed the ␤-gal reporter gene, cells in one of the transfected dishes were fixed in 0.25% glutaraldehyde and stained with X-gal as described (40) . About 80% of the drug-resistant colonies stained blue. Single drug-resistant colonies from SIRC and PAM-212 cells were isolated and amplified, and clones expressing ␤-gal were used in cell culture studies. For the experiments, cells were plated in six-well cluster plates at equal density. The following day, the cells were washed in serum-free medium, and each well was replenished with 1 ml of serum-free medium with and without 1 M TPA (Sigma). The conditioned media were collected after 24 h, and equal volume samples were analyzed by gelatin zymography. gelB was quantitated by densitometry according to our standard methods (41) . Equal amounts of protein sample from the control and TPA-treated cell cultures were used for ␤-gal assays using o-nitrophenyl-␤-D-galactopyranoside as the substrate and a spectrophotometric absorbance of 420 nm, according to a standard protocol (40) .
Development of Transgenic Mice-To prepare DNA for generation of transgenic mice, plasmid Pr43 was cut with EcoRI and HindIII, and the larger 4666-base pair band containing the gelB promoter and lacZ gene was gel-purified from agarose using the Glassmax kit (Life Technologies, Inc.). A similar strategy was used for Pr34 and Pr42. Plasmid Pr35 was cut with NarI and HindIII, and the gelB promoter/lacZ fusion gene fragment was purified for microinjections. Transgenic mice were generated in the core facilities of the Yale Cancer Center (New Haven, CT) and Beth Israel Hospital (Boston, MA). Briefly, fertilized F2 hybrid embryos obtained from matings of C57BL6 and SJL mice were injected with DNA fragments (2 g/ml) and transferred to pseudopregnant Swiss outbred foster mothers. Putative transgenic founder pups born from these foster mothers were analyzed when the pups reached 5 weeks of age. Pups were screened for integration of the transgene into their genomes by Southern blot analysis of DNA from tail biopsies using a ␤-gal DNA fragment as a probe. To determine whether the integrated DNA was transmitted to progeny, founder mice were mated with wildtype CD-1 mice, and tail DNA from the F1 generation progeny was analyzed by PCR. One to two micrograms of tail DNA was subjected to PCR using a forward primer (RM62, 5Ј-CAC CGG CCC TGA GTC AGC ACT-3Ј) complementary to the rabbit gelB gene promoter sequences between Ϫ71 and Ϫ91 and a reverse primer (BF1, 5Ј-CCT CAG TGG ATG TTG CCT TTA CTT-3Ј) specific to the lacZ gene. A positive result was ascertained by the presence of an amplified DNA band of 245 base pairs. The transgene in all cases was found to be incorporated into the germ line since it could be transmitted to offspring according to mendelian genetics, as determined by mating positive heterozygotes with wild-type CD-1 mice (data not shown).
Skin and Corneal Surgeries-Adult transgenic mice (6 -8 weeks old) as well as non-transgenic littermates were anesthetized by an intraperitoneal injection of 2% Avertin (0.017 ml/g of body weight). The back hair from the mice was shaved in a region of 1 cm 2 , and a full-thickness dermal wound (3-4 mm in diameter) was made using a pair of surgical scissors. Bactericidal ointment (Mycitracin, The Upjohn Co.) was applied to the wound, and the mice were allowed to recover under a warming lamp. The mice were sacrificed 1-3 days after surgery, and tissues were processed for ␤-gal staining or histology. A control region of hair was shaved and/or wounded prior to sacrifice. In this case, tissues were excised immediately and processed along with experimental tissues.
For corneal surgery, New Zealand White rabbits (Charles River Laboratories, Wilmington, MA) were used. Rabbits were prepared for surgery by anesthetizing with xylazine and ketamine. Residual reflexes were blocked by topical application of 0.5% proparacaine (Ophthatetic, Alcon, Dallas, TX). An 8-mm diameter circular demarcation was created in the central portion of one eye of each rabbit by gently pressing a trephine on the surface of the cornea. The epithelium within this zone was abraded with an algebrush (Storz Ophthalmic Instruments, St. Louis, MO) to expose the corneal basement membrane. Antibiotic ointment was applied to the eyes, and rabbits were allowed to recover from surgery. Rabbits were sacrificed 20 h after surgery at a time when the migrating epithelial sheet had almost resurfaced the corneal defect. A similar procedure was performed in CD-1 mice (Charles River Laboratories), except that the wound size was 1.5 mm in diameter and the mice were sacrificed 18.5 h after surgery.
Assay of Transgene Expression-Embryos from staged matings between transgenic heterozygous mice and wild-type CD-1 mice were collected from sacrificed females, and tissues were fixed in buffered 4% paraformaldehyde for 25 min, washed three times in PBS, and stained as whole mounts in buffered 2% X-gal solution at 30°C for 5-12 h (40). Embryos past embryonic day 15 (E15) were cut sagittally in half and processed. Adult organs or tissues were surgically removed from the mice, cut into smaller pieces, and fixed and stained as described above. After staining, the tissues were washed in PBS, refixed in 4% paraformaldehyde, and photographed immediately. Some tissues were then embedded in paraffin, sectioned (6 m), and stained with hematoxylin and eosin.
Electrophoretic Mobility Shift Assay (EMSA)-To collect tissue to prepare nuclear extracts, rabbits were anesthetized, transferred to a cold room, and sacrificed by intracardiac injection of phenobarbital. The corneal epithelium within a 9-mm centrally demarcated region from wound-healing (six) eyes or uninjured (six) eyes was removed by abrasion with a No. 10 Bard Parker surgical bade. Tissue was transferred to a 1.5-ml microcentrifuge tube containing 0.6 ml of ice-cold 10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 5 mM NaF, and 1 mM each dithiothreitol, phenylmethylsulfonyl fluoride, benzamidine, aprotinin, spermidine, antipain, and leupeptin. The pooled wound-healing epithelial tissue and separately pooled control tissue were homogenized on ice with the aid of a microcentrifuge homogenizer. The remaining steps essentially followed the procedure of Dignam et al. (42) . Equal aliquots of equal protein were frozen at Ϫ70°C. Nuclear extracts were prepared from corneal epithelial cells in a similar manner.
For EMSA, the double-stranded oligonucleotides containing the canonical DNA-binding sites for transcription factors AP-1 (5Ј-CGC TTG ATG ACC AGC CGG AA-3Ј), NF-B (5Ј-AGT TGA GGG GAC TTT CCC AGG-3Ј), Sp1 (5Ј-ATT CGA TCG GGG GGG GCG AGC-3Ј), and AP-2 (5Ј-GAT CGA ACT GAC CGC CCG CGG CCC GT-3Ј) were purchased from Promega (Madison, WI). Two double-stranded oligonucleotide probes (RM70, 5Ј-GGA GGA CGT AGC CTG CGG GAG AGC CTC A-3Ј, and its complementary strand, RM71; and RM72, 5Ј-TCA AGG GTG GGC CTG GGG TGG CAC TCA-3Ј, and its complementary strand, RM73) that contain the two AP-2 DNA-binding sites from the upstream region of the gelB promoter (see Fig. 1 ) located between Ϫ412 and Ϫ420 and between Ϫ368 and Ϫ375, respectively, were used as probes in EMSA. Briefly, 0.03 pmol of radiolabeled DNA (43) was incubated for 20 min at room temperature with equal amounts of nuclear extracts (1-2 g) from tissues or cell cultures in a high salt DNA-binding buffer containing poly(dI-dC) (Promega). The protein-DNA complexes were resolved by electrophoresis on a 4% nondenaturing polyacrylamide gel, and gels were dried and exposed to x-ray film for autoradiography. For supershift EMSA assays, protein-DNA complexes were incubated with antibodies for an additional 40 min and resolved by gel electrophoresis. Antibodies for supershifts were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Immunolocalization Studies-Frozen serial sections of wound-healing mouse eyes were processed for immunostaining according to standard methods (44) . Antibodies (Santa Cruz Biotechnology) were diluted in PBS (anti-Sp1, 1:500; anti-AP-2, 1:100; and anti-NF-B (p65), 1:500). An anti-fibronectin antibody, R61 (a gift from Dr. Richard Hynes, Massachusetts Institute of Technology), was diluted 1:400 in PBS. Sections were blocked in normal goat serum, and antibodies (or normal rabbit serum) were applied to the sections for a 3-h incubation at room temperature. After washing, sections were incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (diluted 1:50 in PBS) for 45 min and then washed again. Slides were photographed by epifluorescence.
RESULTS

Development and Analysis of SIRC-43 and PAM-43, Two Stably Transfected Cell Lines Containing the gelB Promoter/ lacZ Fusion Gene-
We recently demonstrated that the DNA sequence between bases Ϫ519 and ϩ19 of the rabbit gelB gene promoter drives expression of a chloramphenicol acetyltransferase reporter gene transiently transfected into cultured cells in a manner similar to the endogenous gelB gene (37) . The base position at Ϫ519 interrupts an NF-B-binding motif located between Ϫ522 and Ϫ514, which was shown to be important for human gene response to tumor necrosis factor-␣ (36) . Therefore, we designed a new reporter gene construct for the current studies, Pr43, which includes 3 additional bases up to Ϫ522 (Fig. 1) . We also replaced the chloramphenicol acetyltransferase reporter gene with LacZ to facilitate localization of expressing cells and utilized a new cloning vector containing a neomycin aminoglucotransferase gene for selection of stably transformed cells. To analyze the relationship between endogenous gelB gene expression and promoter activity of Pr43 in parallel, we developed two stably transformed keratinocyte cell lines, SIRC-43 and PAM-43. When plated in culture wells at equal density, each cell line exhibited constitutive ␤-gal activity, but at different levels. When treated with TPA, a 2-fold induction of ␤-gal activity was observed in SIRC-43; a much larger 8-fold induction was observed in PAM-43 cells (Fig. 2,  left panels) . Zymographic analysis of conditioned media from the same cultures used for ␤-gal analysis revealed gelB in the proenzyme form. In the rabbit corneal epithelial cell line SIRC-43, gelB ran as a doublet of glycosylated and non-glycosylated forms with the same relative mobility as the rabbit gelB standards. In the mouse epidermal cell line PAM-43, gelB ran as a single 105-kDa band, as expected for mouse gelB (Fig. 2, right  panels) . The endogenous gelB gene was induced only 2-fold in SIRC-43 cells, similar to the -fold induction of the ␤-gal reporter gene. In contrast, gelB expression was induced dramatically by TPA in PAM-43 cells, from essentially undetectable levels to a level as high as in TPA-treated SIRC-43 cells. These data indicate that the Ϫ522 to ϩ19 gelB promoter drives ␤-gal
The DNA between Ϫ522 and ϩ19 of the rabbit gelB gene was fused to the lacZ gene in pcDNA3, which contains the neomycin aminoglucotransferase gene for G418 drug resistance. The functionally characterized transcription factor response elements in the promoter are shown; base numbering is with respect to the transcriptional start site (ϩ1) of the rabbit gene. These elements were characterized in the following genes: AP-1, human and rabbit genes; PEA3, human gene; NF-B, human and mouse genes; proximal Sp1, mouse and human genes; distal Sp1, human gene; AP-2 sites (filled boxes), rabbit gene. Two AP-2-like sites (cross-hatched boxes) fit the binding sequence consensus, but have not been functionally characterized. The references for promoter characterization are as indicated: human gene (36, 38) , mouse gene (35) , and rabbit gene (37) .
reporter gene expression in cultured keratinocytes in a manner closely paralleling the endogenous gelB gene.
Embryonic Expression Pattern of the gelB Promoter/lacZ Fusion Gene in the Mouse
Line 3445-We next tested the activity of the Ϫ522 to ϩ19 gelB promoter fragment cloned into Pr43 in transgenic mice. Injection of the excised EcoRI-HindIII fragment from Pr43 containing the gelB promoter/lacZ fusion gene (Fig. 1) into the pronuclei of fertilized mouse eggs resulted in five transgenic founders. Founders were mated with wildtype mice, and the resulting F1 embryos were analyzed for developmental ␤-gal expression patterns by histochemical staining of whole mounts. Genetics predicts that approximately half of these embryos would be of the heterozygote genotype and half of the wild type; the latter provided an internal negative control for assessment of endogenous ␤-gal activity (not due to the transgene). Two of the five transgenic lines were found to express the transgene. Southern blotting revealed that both mouse lines contained between 1 and 10 copies of the transgene (data not shown). In Figs. 3 and 4 , we show examples of the expression pattern of line 3445, which was the strongest; expression of line 3433 was similar but weaker.
At embryonic day 11 (E11), histochemical staining for ␤-gal activity occurred in the head region patterned to the more ventral portions of the developing brain and neural tube, especially in the developing mesencephalon and hindbrain (Fig. 3, a  and c) . A second prominent region of staining occurred in the schlerotomic fissures of the somites, which were outlined by stain (Fig. 3a) . At E11 (Fig. 3b) and later in development, littermates that did not carry the transgene were negative for ␤-gal staining. E13 embryos continued to show intense staining along the neural tube (Fig. 3d ), but staining in brain was reduced, being confined to the germinal cells lining the lateral ventricle and the fourth ventricle as viewed in sagittal sections (data not shown). Developing whisker follicles were lightly stained, and staining in the eye and nasal cavities was intense (Fig. 3d) . Staining in the area of the developing posterior vertebrae was seen, and prominent staining was observed in the regions of developing limb bones and in developing jaw bones (Fig. 3d) . At E15, whole mounts revealed continued staining of the eye (data not shown). Embryos cut in half revealed staining in ventricular aspects of the brain, the nasal cavities, the developing vertebrae, and the endochondral plates of the developing rib bones (Fig. 4a) . Staining in developing jaw bones was even stronger than at E13 (data not shown), and in addition, staining around the incisors and in the cartilaginous roof of the mouth was observed (Fig. 4b) . Staining in developing limb bones also continued to be apparent at E15, especially strong in long bones, the metatarsus/metacarpus, and the tips of the digits (Fig. 4d) .
The prominent localization of gelB promoter activity to developing bones and neural tissue in embryos of the transgenic line 3445 parallels the major sites of endogenous gene expression as described in several recent reports (18 -20, 22) . To document the degree of similarity further, we examined the pattern of gelB promoter activity at the cellular level in sagittal sections from whole mounts. Expression of the transgene was observed in cells of the first branchial arch of the mandible at E11 (data not shown). In E15 embryos, transgene expression was seen to localize around the incisors of the upper and lower jaws (Fig. 4c) . The tooth germs themselves did not stain, but ␤-gal expression could be seen in the maxillary and mandibular bones. Meckel's cartilage, which does not express endogenous gelB, also did not show ␤-gal activity (data not shown). In sections through the forelimb plate, staining was found to be localized in the highly vascularized mesenchymal tissues of the digits (Fig. 4e) . Sagittal sections that traversed diagonally to the plane of the metatarsus also revealed staining in developing muscle (Fig. 4f) . ␤-gal expression was observed in the mesenchymal cells within the fissures surrounding the somites remaining in the posterior of the embryo (Fig. 4g) . In addition, (n ϭ 4) . Right panels, gelatin zymography of conditioned media samples (equal volumes) from the cell cultures that were used to make lysates. Rabbit gelB standards, as well as reduced molecular mass standards, were run in parallel for sizing of the zymogram bands (not shown). Rabbit gelB migrates at 92 kDa, which is observed as a doublet of glycosylated and non-glycosylated forms, whereas mouse gelB migrates at 105 kDa.
the endochondral plates of the developing rib bones and the cells surrounding the membranous bone of the clavicle stained positive (data not shown). These cellular patterns of gelB promoter activity in developing bone and cartilage closely parallel the expression patterns described for the endogenous gelB gene (18, 19, 22) .
Sections from mouse embryos at E11 showed that staining occurred in germinal zone cells lining the lateral ventricles and the fourth ventricle (data not shown). At E13, the ependymal cells approaching the choroid plexus of the brain and the mesenchyme of the optic region were highly vascularized. In the choroid plexus of the fourth ventricle, mesenchymal precursors also showed strong staining (Fig. 4i) . Strong expression of ␤-gal was observed in the cells lining the lateral ventricle (data not shown) and in the cells lining the perivascular space along the choroid fissure extending up to the hippocampal area (Fig. 4j) . These staining patterns in vascularizing neural tissues closely parallel the previously reported patterns of endogenous gene expression (20) . Staining was also found in other vascularized areas such as the umbilical vein, where expression was localized to the endothelium, epidermis, and mesenchymal cells (Fig. 4h) .
Comparison of gelB Promoter/lacZ Fusion Gene Activity in Migrating Epithelial Cells in Culture and in Mice-MMPs are expressed in the migrating sheet of the epithelium during wound healing in skin or cornea. Migrating epithelial sheets can be modeled in cell culture by plating cells at cloning density; as the colony expands, the cells migrate outward as a sheet. We stained single colonies of SIRC-43 and PAM-43 cells to learn whether the gelB promoter activity shows differential expression at the edge of the colony (where cells are migrating outward) versus the center of the colony (where cells are stationary). However, staining was found to be uniform in all cells of the colonies examined, with no specific up-regulation at the migrating edge or down-regulation near the center. An example of this result using the SIRC-43 cells is shown in Fig. 5a .
The situation was much different when promoter activity was examined in vivo in line 3445 transgenic mice. Acute full-thickness skin wounds allowed to heal for 1, 2, or 3 days showed positive ␤-gal activity along the wound margin and within hair follicles in the region of skin that was shaved prior to wounding (Fig. 5b) . Staining was also observed in the muscle layer. Wound-healing skin of non-transgenic mice did not stain, indicating that staining was due to expression of the transgene (Fig. 5c) . Sectioning of the healing skin tissue from transgenic mice revealed localization of stain in the basal epidermal keratinocytes at the migrating front, in scattered cells within the dermal area at the wound edge, in hair follicles, and in glands (Fig. 5, d and e) . A similar pattern of transgene expression was observed in partial thickness corneal keratectomy wounds (to be described elsewhere). 3 Both shaving and plucking of the skin hairs induced expression of the transgene in hair follicles independent of wounding (data not shown). This is consistent with reports that endogenous gelB is expressed during specific stages of the hair cycle (45) . The transgenic mouse line 3433 also showed wound-specific activation of the promoter similar to line 3445 (data not shown); the other three transgenic lines did not express the transgene. These findings reveal that the Ϫ522 to ϩ19 gelB gene promoter confers the capacity for injury-specific induction of the reporter gene in a manner that closely parallels expression of the endogenous gene as described in recent publications (23) (24) (25) (26) (27) .
Sequence Requirements for gelB Promoter/lacZ Promoter Activity in Epithelial Cell Culture and in Vivo-We previously examined the effects of progressive 5Ј to 3Ј cutback of the DNA sequences between Ϫ519 and Ϫ92 on promoter activity in cultured cells (37) . Deletion to base Ϫ438, removing regulatory elements up to and including the distal AP-1-binding site, resulted in a dramatic loss of promoter activity. However, continued deletion to base Ϫ92 restored promoter activity. This suggested that DNA sequences between Ϫ438 and Ϫ92 might bind factors that inhibit the activity of the gelB promoter in cultured cells. However, we also showed that this DNA contains binding sites that enable positive response to transcription factor AP-2.
In this study, we further examined the activity of the internal DNA sequences by deletion analysis. Four new reporter constructs were generated. The basal activity of the new promoter constructs was compared in SIRC cells and in the rabbit synovial fibroblast cell line HIG-82 (Fig. 6) . The activity of the minimal promoter in Pr34 was lower than in Pr22 in both cell lines, which reflects (at least in part) the loss of the NF-B, Sp1, AP-1, and PEA3 response element combination clustered at the distal end of the Pr22 promoter. Addition of this response combination to the minimal promoter in Pr35 (along with a short portion of more distal sequence) resulted in a substantial gain in basal activity, to a level even greater than that of Pr22. However, expression of Pr22 could be induced 9.6-fold by TPA, but TPA treatment induced Pr35 activity only slightly, indicating that important regulatory elements were missing in this construct. Addition of sequences between Ϫ522 and Ϫ313 to the minimal promoter in Pr42 also resulted in an increase in 3 R. Mohan and M. E. Fini, unpublished data. 
FIG. 4.
Localization of gelB promoter activity to highly vascularized areas of developing cartilage, bone, and neural tissue in embryos of mouse line 3445. gelB promoter activity was detected by histochemical localization of ␤-gal expression in whole mounts of E15 embryos (a, b, and d) and thin sections cut from E15 (c, e, f, and h) and E13 (g, i, and j) ␤-gal-stained whole mounts counterstained with eosin or with hematoxylin and eosin. a, whole mount cut in half sagittally reveals staining in ventricular aspects of the brain and in the rib bones (arrow), nasal cavity, jaw structures, and developing vertebrae (arrowhead). b, a higher magnification of the snout portion of the embryo shown in a reveals intense staining localized to developing bone surrounding the emerging incisors (white and black arrows). c, sagittal section through the snout area reveals ␤-gal expression in osteoclasts around the incisor (arrow) and in mesenchymal tissue (arrowheads). d, close view of whole mount reveals ␤-gal staining in the metatarsi (white arrow) and in the tips of the digits (black arrowhead) of the paw. e, sagittal section through the forelimb shown in d reveals strong ␤-gal activity in vascularized regions around the developing bones of the fingers (arrowhead). f, tangential section through the digit of the paw shown in d reveals ␤-gal staining in developing muscle (arrowhead) and in mesenchymal tissue (arrow) of the digits. promoter activity; however, activity was only half that of the full-length promoter. These results indicate that the internal region of the gelB promoter contains sequences that contribute positively to promoter activity.
We next examined the activity of Pr35, Pr42, and Pr34 in transgenic mice. Genetic crosses revealed germ line transmission from seven Pr35 founder mice, nine Pr42 founder mice, and eight Pr34 founder mice. However, no expression of the ␤-gal reporter gene was observed in adult tissues from any of these lines (Fig. 6 ). These mice also showed no evidence of wound-induced ␤-gal reporter gene expression. Analysis of the embryonic staining pattern of Pr42 mouse embryos revealed that the transgene was also inactive during development. Only one of the lines showed expression in the embryo at E11 (data not shown). Here, very faint staining for ␤-gal activity was observed in the eyes. The adult F1 generation from this founder (line 889) showed strong staining in the rib bones of the skeletal system (data not shown). However, this staining pattern did not match that of mouse lines 3433 and 3445 or that of the endogenous gelB gene. These findings suggest that sequences between Ϫ438 and Ϫ92 are required for appropriate promoter activity in vivo.
Transcription Factor Activity in Epithelial Cell Cultures and in Vivo-gelB is constitutively expressed in cultures of corneal epithelium, but its expression in adult normal corneal epithelium is absent (14, 25, 26) . To learn whether differences in specific transcription factor activities could help explain this finding, we compared nuclear extracts from primary cultures of rabbit corneal epithelial cells with extracts from corneal epithelial tissues taken directly from rabbit eyes.
We utilized a canonical AP-2 oligonucleotide to characterize the AP-2/AP-2-like proteins present in nuclear lysates of corneal epithelial cell cultures. A strong broad band and a weaker band with slightly slower mobility were observed in EMSA (Fig. 7A, left panel) . These complexes contained AP-2-like protein(s) since they were mostly competed with a molar excess of unlabeled AP-2 oligonucleotide, but not by a nonspecific Sp1 oligonucleotide with a related sequence (Fig. 7A, left panel) .
However, incubation of the DNA/protein reaction mixtures with anti-AP-2 antibodies supershifted primarily the minor complex (Fig. 7A, arrowheads) . A nonspecific Sp1 antibody had no effect.
A different EMSA banding pattern was produced when the AP-2 probe was incubated with nuclear lysates of epithelial tissue. Here, the major protein-DNA complex displayed a relatively slower mobility compared with that observed in EMSA of cell culture nuclear lysates (Fig. 7A, middle panel) . Again, the complex was competed by unlabeled AP-2 probe, but not by an unrelated Sp1 probe. The major EMSA band is actually a closely spaced doublet; this is not readily obvious in the figure, but is clear on shorter exposures of the gel to x-ray film (data not shown). AP-2 antibodies supershifted this doublet completely (Fig. 7A, arrowheads) . As observed with cell culture lysates, the nonspecific anti-Sp1 antibody did not alter the mobility of the complex.
We were also able to detect binding activity from epithelial cell and epithelial tissue lysates for NF-B, Sp1, and AP-1 DNA probes. Results for the NF-B probe are shown in Fig. 7A . Epithelial tissue extracts incubated with the NF-B probe produced two major bands on EMSA (Fig. 7A, right panel) . Competition with unlabeled NF-B oligonucleotide abolished the broad upper band and most of the lower band. The upper band is actually a closely spaced doublet; the upper sub-band shifted with antibodies specific for the NF-B subunit p65, and the lower sub-band shifted with antibodies to the p50 subunit. Nonspecific antibodies and unrelated unlabeled oligonucleotide did not alter the EMSA banding pattern (data not shown). In contrast to the results with AP-2, no qualitative differences between corneal epithelial cell culture lysates and epithelial tissue lysates were observed for the NF-B probe, which was also the case with the Sp1 and AP-1 probes (data not shown).
We next determined whether AP-2 DNA-binding elements from the rabbit gelB promoter formed complexes similar to the canonical oligonucleotide. Fig. 7B shows the results of EMSA analysis using lysates from epithelial tissue. Probes representing bases Ϫ412 to Ϫ420 (oligonucleotide RM70/71) or bases Ϫ368 to Ϫ375 (oligonucleotide RM72/73) of the gelB promoter, both of which contain AP-2-binding sites as determined by footprinting with recombinant AP-2 (37), produced EMSA banding patterns very similar to those produced by the canonical AP-2 probe (Fig. 7B , left and right panels, respectively). In addition, competition with unlabeled probe and antibody supershift results were also comparable. EMSA with lysates from epithelial cell culture revealed a different EMSA banding pattern, similar to that observed with the canonical AP-2 probe (data not shown). We conclude that different types of AP-2 complexes associate with the gelB promoter in cultured corneal epithelial cells as compared with epithelial tissues. This could offer some explanation for the differential expression of gelB.
Transcription Factor Activity in Normal and Migrating Epithelia in Cell Culture and in Vivo-As a first step to elucidate mechanisms of wound-induced transcriptional activation of gelB expression, we compared the activity, expression, and localization of specific transcription factors involved in gelB promoter regulation in normal rabbit corneal epithelium and in epithelium migrating to heal a wound. Analysis was done on rabbit corneas (rather than mouse) to take advantage of the larger tissue area. EMSAs of nuclear lysates derived from normal and migrating corneal epithelia revealed similar banding patterns for transcription factors Sp1, AP-2, NF-B, and AP-1 in both normal and migrating corneal epithelia (Fig. 8A) . In the case of Sp1, a new minor band appeared when analysis was done with nuclear lysate from migrating tissue that was not seen when nuclear lysate from normal tissue was used. The overall level of DNA-binding activity was quite striking for the Sp1 probe. DNA-binding activity for transcription factors AP-2 and NF-B was also up-regulated, although not to as dramatic a level as for Sp1. The DNA-binding activity of AP-1 was roughly equivalent in both wound-healing and normal corneal epithelia.
The expression and localization of NF-B, Sp1, and AP-2 proteins in migrating corneal epithelium were determined by immunofluorescence analysis. To mark the region of the wound, we stained for fibronectin (Fig. 8B, panel d) , which is deposited into the wound bed from the tear film. The p65 subunit of NF-B was found in all epithelial cell layers (panel c). Its expression was not increased in the migrating cells; however, it appeared to be more distinctly localized to the nuclear compartment in these cells, consistent with the EMSA results. Sp1 was also detected in the basal and suprabasal cell layers of the epithelial sheet (panel a). Unlike NF-B, Sp1 was distinctly localized to nuclei in both stationary and migrating cells, but expression was considerably stronger in nuclei of migrating cells (panel a, arrowhead) . A third pattern was seen for AP-2, whose expression was distinctly nuclear in stationary and migrating epithelia, like Sp1, and whose expression was dramatically up-regulated in the migrating cells (panel b). Un- like both NF-B and Sp1, however, AP-2 was not expressed throughout the cell layers of the epithelium, but was confined predominantly to the basal cell layer. Together, these results indicate that the activity of transcription factors Sp1, AP-2, and NF-B is up-regulated in migrating epithelial cells and that this increased activity overlaps in the basal cells of the migrating epithelium, the location of gelB expression.
DISCUSSION
In this paper, we show that the DNA sequences contained between Ϫ522 and ϩ19 of the rabbit gelB gene constitute a minimal in vivo promoter that drives appropriate reporter gene expression in stably transfected keratinocyte cell lines and in transgenic mice. The pattern of ␤-gal reporter gene expression captured in the transgenic mouse line 3445 faithfully depicts the spatial and temporal developmental pattern of endogenous gelB gene expression as demonstrated by in situ hybridization analyses reported by several different laboratories (17) (18) (19) (20) 22) . The mouse line 3445 also displays appropriate injury-specific induction of reporter gene expression (23) (24) (25) (26) (27) 45) .
Transgenic mice allow the study of promoter characteristics in situations for which cell culture models clearly cannot substitute, such as developmental regulation in the complex environment of the embryo (46) . However, cell culture models are often used to represent aspects of wound healing such as keratinocyte migration (47) . Here, we show some of the deficiencies of cell culture models for characterization of MMP promoter activity. First, we could not create a situation in cell culture in which the gelB promoter was entirely inactive, as it is in intact corneal epithelium or skin epidermis. The activity of the Ϫ522 to ϩ19 promoter in the stably transfected keratinocyte lines SIRC-43 and PAM-43 very closely paralleled the activity of the endogenous gelB gene, but this gene was expressed constitutively, as occurs in keratinocytes migrating to heal a corneal (25) (26) (27) or skin (23, 24) wound in vivo. Second, analysis at the single cell level revealed that gelB promoter activity was uniform throughout cultures; it was not increased at the edges of migrating colonies or reduced at their centers. Yet the same promoter was found to drive ␤-gal expression specifically in the migrating epithelium during re-epithelialization of injured skin and corneas of line 3445 transgenic mice, whereas the gelB promoter remained inactive behind the migrating cells in the region of uninjured epidermis or the corneal epithelium. Third, transient transfection analysis revealed that much of the DNA between Ϫ522 and ϩ19 of the promoter could be eliminated without compromising basal promoter activity, whereas all of the DNA was required for promoter activity in vivo. These differences in promoter activity when analyzed in cell culture and transgenic mice may reflect differences in transcription factor expression and activity. In fact, we show that the corneal epithelium differs from cultured epithelial cells with respect to the types of complexes that form on an AP-2 DNA-binding probe. The differences in complex size may indicate different protein composition, which might be important in determining the activity of the gelB promoter. Overall, this work emphasizes the drawbacks of cell culture for analysis of the factors that control promoter activity in vivo.
Binding sites for transcription factor AP-1 are essential for gelB promoter activity in cultured cells (35, 37, 38) , as is true for several other MMP genes. In addition, binding sites for transcription factors NF-B, PEA3, and Sp1 determine promoter response to specific stimuli (35, 36, 38) . All of these elements are clustered within two regions at the proximal or distal ends of the Ϫ522 to ϩ19 promoter region characterized in this study. The stretch of DNA between these clusters (Ϫ438 to Ϫ92) is not essential for promoter activity in cell culture (37); nevertheless, much of the sequence is highly conserved among humans, mice, and rabbits, suggesting functional importance. In fact, we previously showed that DNA sequences within a portion of this region (Ϫ423 to Ϫ330) confer selectivity of promoter activity for cultured corneal epithelial cells as opposed to corneal fibroblasts, and we localized this activity to three response elements for AP-2 (37) . More important, we show that these internal sequences are essential for the activity of the promoter in transgenic mice. Furthermore, this requirement is not confined to the Ϫ423 to Ϫ330 internal sequences that contain the characterized AP-2 sites: all of the internal promoter region is required. The concept that emerges from this work is that the in vivo situation imposes more stringent requirements; multiple cis-acting elements in the gelB promoter are therefore required to provide sufficient impetus for promoter induction.
The cornea offers an unusually accessible model to study transcription factor activity in wound healing, as the epithelium can be rapidly and easily isolated as a pure tissue from both normal and healing corneas. We utilized this model to begin analysis of factors that could determine gelB promoter induction in the migrating epithelium. By EMSA, we demonstrated constitutive DNA-binding activity in nuclear extracts from the normal, uninjured corneal epithelium for four of the defined regulatory elements in the gelB promoter: AP-1, NF-B, Sp1, and AP-2. In the migrating epithelium, the amount of binding activity for the AP-1 probe present in nuclear extracts was the same as in the stationary epithelium. However, binding activity for NF-B, Sp1, and AP-2 DNA probes was clearly elevated. For NF-B, increased nuclear translocation of the existing p65 subunit appeared to occur in the migrating epithelium, explaining the induction of binding activity. Sp1 and AP-2 were already localized to nuclei; however, induced binding activity could be explained by a striking increase in the amount of these proteins in nuclei of migrating cells. The composition of the DNA-binding complexes and their relative capacity to stimulate transcription still needs to be examined. Nevertheless, these results suggest that the combined induction of several transcription factors necessary for gelB promoter activity occurs in the migrating epithelium, and this provides a focus for further experiments.
GelB promoter activity is induced in migrating epithelial cells in vivo, but only in the basal cell layer. Our immunolocalization studies revealed that NF-B and Sp1 are present in all layers of the corneal epithelium, and these factors could therefore not determine such localized expression. In contrast, we confirm reports that AP-2 is found predominantly in the basal cell layer of the corneal epithelium (48), 4 similar to its localization in another stratified epithelium, the skin epidermis (50) . AP-2 is a tissue-specific transcription factor confined to tissues derived from embryonic ectoderm and neural crest (51) . AP-2 controls expression of the keratins, which are cytoskeletal proteins expressed by the keratinocytes composing tissues of body surface epithelia such as the skin and cornea (52) . Recent evidence has been published (53) suggesting that preferential stimulation of AP-2 DNA-binding activity in the basal layers of the corneal epithelium (or skin epidermis) is an important determinant of keratin gene switching during differentiation of the keratinocytes. A requirement for localized transcription factors such as AP-2 along with more widespread transcription factors such as Sp1 might similarly confine expression of gelB to the basal cell layers of corneal and skin epithelia migrating to cover a wound.
What determines the localized induction of Sp1 and AP-2 expression to the epithelium migrating over the wound bed? As the epithelium migrates outward from the edge of a wound, it loses contact with its basement membrane and moves across a provisional matrix deposited from the tear film in the cornea (54) and the vasculature in skin (55) . We showed that the location of fibronectin deposited from the tear film beneath the migrating epithelium precisely defines the realm of Sp1/AP-2 up-regulation. This invites us to speculate that reciprocal interaction between keratinocytes and their ECM might control the expression of Sp1 and AP-2. The control by the ECM on signaling the activity of transcription factors has recently emerged as a novel concept (56) . Additional experiments to address the role of ECM components in modulating Sp1 and AP-2 DNA-binding activities and distribution in epithelial cells during wound healing need to be performed to address this idea.
Attenuation of gene expression through the use of transcriptional inhibitors is a novel strategy to control inflammatory and stress-related disorders. Transcription factors AP-1 and NF-B have attracted much interest for drug targeting because they are so widely involved in these pathologies (57) . Currently, transcriptional inhibitors are being tested on artificial gene promoters that contain single or multiple copies of response elements for a particular transcription factor (49) . However, it is necessary to extend testing to response elements in their natural context because transcription factors are known to cross-couple their activities by interacting among themselves and with other transcriptional co-activators; this can significantly modulate gene expression profiles (32) . We propose the gelB gene promoter as a model for the extension of drug tests into a physiological context. Like other MMPs, it is inducible by a variety of stress stimuli (4) . Its advantage over the promoters of other MMP genes lies in the diversity of characterized stressactivated response elements that it harbors. Thus, whereas AP-1 response elements have been identified in most of the MMP genes, gelB contains an important NF-B DNA-binding site that has not been defined in other MMP promoters to date (4) . Like other MMP genes, gelB also contains an important transcription factor ets response element (PEA3), but it also contains AP-2 and Sp1 response elements, which are more specific for this particular MMP gene. Therefore, we propose the SIRC-43 and PAM-43 cell lines and the transgenic mouse line 3445 as useful tools for identifying transcriptional inhibitors of gelB gene expression, which in some cases may be extended to other MMPs.
In conclusion, we present the first study on the activity of a MMP promoter in transgenic mice. We suggest that line 3445 transgenic mice, which express ␤-gal under control of the gelB promoter, provide a model to study regulation of gelB gene expression in development, tissue repair, and disease. In addition, these mice will be a useful tool for the in vivo testing of drugs to control MMP activity in pathology.
